• OPEN AN ACCOUNT
Indian Indices
Nifty
25,227.35 -58.00
(-0.23%)
Sensex
82,327.05 -173.77
( -0.21%)
Bank Nifty
56,625.00 15.25
( 0.03%)
Nifty IT
35,330.80 -278.25
( -0.78%)
Global Indices
Nasdaq
45,502.84 -876.59
(-1.89%)
Dow Jones
6,574.01 -182.10
(-2.70%)
Hang Seng
48,192.70 -387.74
(-0.80%)
Nikkei 225
9,427.47 -81.93
(-0.86%)
Forex
USD-INR
88.81 0.04
(0.05%)
EUR-INR
103.01 -0.16
(-0.15%)
GBP-INR
118.58 -0.38
(-0.32%)
JPY-INR
0.58 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

AstraZeneca Pharma slides as Head of Legal Pankaj Jain resigns
Sep 19,2025
According to the company’s statement, Jain has decided to pursue opportunities outside the organization. He will complete the handover process by the close of business on 31 October 2025.

AstraZeneca Pharma India also informed that it is in the process of identifying a suitable replacement for the position. The company extended its appreciation to Jain and wished him success in his future endeavors.

AstraZeneca Pharma is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory and Rare Disease.

The company’s standalone net profit surged 60.1% to Rs 56.08 crore on 35.8% increase in revenue from operations to Rs 526.31 crore in Q1 FY26 over Q1 FY25.